AZTR

Azitra's stock price has declined significantly over the past year. In May 2026, Azitra announced a new U.S. patent for ATR-12, but the stock price declined. In April 2026, Azitra presented on ATR-01, pursued reverse stock splits, and awarded stock options to executives, with momentum indicators turning positive. In March 2026, Azitra announced a private placement financing, causing the stock to jump, and received a NYSE non-compliance notice. In February 2026, Azitra reported full-year 2025 results and initiated the ATR-04 Phase 1/2 trial. In November 2025, Azitra reported Q3 2025 earnings and received a NYSE non-compliance notice. The stock has recently shown stronger performance in shorter time frames.